DEAL NOTE: Crowell Represents Marshall Wace in $41.5 million Series B Financing of Parse Biosciences
Firm News | 1 min read | 02.16.22
San Francisco – February 16, 2022: Crowell & Moring represented Marshall Wace, a global alternative investment manager, in a $41.5 million Series B round of funding of Parse Biosciences. Marshall Wace co-led the transaction with Janus Henderson Investors, with Soleus Capital, Logos Capital and Bioeconomy Capital also participating. Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research through their pioneering approach for single cell sequencing. Single-cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system. The transaction was led by partners Jon O'Connell (San Francisco) and Anne Li (New York), and included partners Rashad Morgan (Chicago), counsel Matt Pelnar (San Francisco), and associates Karla Arias (Washington, D.C.) and Justin Lurie (New York).
Insights
Firm News | 2 min read | 09.20.24
Crowell & Moring Secures Zero-Payment Dismissal for BMW Group Against Infogation
Crowell & Moring LLP is pleased to announce that firm client BMW Group has achieved a zero-payment dismissal with prejudice in two cases brought by Infogation Corporation (“Infogation”) against Bayerische Motoren Werke AG (“BMW AG”) and BMW of North America, LLC (“BMW NA”) involving U.S. Patent Nos. 10,107,628; 8,898,003; 8,406,994; and 6,292,743 (“Patents-in-Suit”), before the U.S. District Court for the Eastern District of Texas.
Firm News | 2 min read | 09.17.24
Firm News | 2 min read | 09.10.24
John Koenigsknecht and Andrew Avsec Named as Crain’s Chicago Business 2024 Notable Leaders in Law
Firm News | 2 min read | 09.09.24
Daily Journal Names Jason Murray and Chahira Solh to 2024 Top 100 Lawyers List